Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
a and c meningococcal polysaccharide vaccine
- Development stage
- Unknown
- Lead developer
- Sanofi
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Subcutaneous
01
Overview
A and C meningococcal polysaccharide vaccine is an inactivated bacterial vaccine composed of purified capsular polysaccharides from Neisseria meningitidis serogroups A and C. It is designed to induce active immunity against invasive disease caused by these two serogroups. The mechanism of action involves stimulating the immune system to produce specific antibodies against the capsular antigens of N. meningitidis A and C, thereby providing protection if exposed to these bacteria. This type of vaccine does not contain protein conjugates; it consists solely of the purified polysaccharides from each serogroup.
- Other names
- meningococcal polysaccharide vaccine groups a and cmen a+c vaccineac meningitis vaccine
02
Targets
Neisseria meningitidis group C capsular polysaccharideNmA CPS (Neisseria meningitidis group A capsular polysaccharide)
Beyond the preview
Go deeper on a and c meningococcal polysaccharide vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on a and c meningococcal polysaccharide vaccine.